Matches in Wikidata for { <http://www.wikidata.org/entity/Q91018090> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q91018090 description "2019 թվականին հրատարակված գիտական հոդված" @default.
- Q91018090 description "article scientifique (publié 2019)" @default.
- Q91018090 description "articolo scientifico (pubblicato il 2019)" @default.
- Q91018090 description "artigo científico (publicado na 2019)" @default.
- Q91018090 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q91018090 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91018090 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91018090 description "scientific article published on 01 January 2019" @default.
- Q91018090 description "wetenschappelijk artikel" @default.
- Q91018090 description "наукова стаття, опублікована 1 січня 2019" @default.
- Q91018090 description "научна статия" @default.
- Q91018090 name "Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease" @default.
- Q91018090 name "Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease" @default.
- Q91018090 name "Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease" @default.
- Q91018090 type Item @default.
- Q91018090 label "Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease" @default.
- Q91018090 label "Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease" @default.
- Q91018090 label "Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease" @default.
- Q91018090 prefLabel "Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease" @default.
- Q91018090 prefLabel "Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease" @default.
- Q91018090 prefLabel "Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease" @default.
- Q91018090 P1433 Q91018090-DF8CBFBB-DA15-4457-899D-8B5930D7B6DE @default.
- Q91018090 P1476 Q91018090-6E9F56CA-A9A2-4A61-AAE5-EF7D09FF478D @default.
- Q91018090 P2093 Q91018090-3AFE85BC-870D-4088-A41F-5E26DC47307F @default.
- Q91018090 P2093 Q91018090-5E2578BD-7E20-476F-B6B0-1D5D25D55C0F @default.
- Q91018090 P2093 Q91018090-8427A57D-E4C6-4A03-A515-CFDA91045373 @default.
- Q91018090 P2093 Q91018090-94FFD75C-455D-4C07-B6C3-0B172FF5C6AC @default.
- Q91018090 P2093 Q91018090-A1D0C09F-E70E-4444-99CA-76DC77362135 @default.
- Q91018090 P2093 Q91018090-C101F20B-A099-4946-9A59-66104BF22982 @default.
- Q91018090 P2093 Q91018090-DB8F8018-C12F-4AF5-9B7A-1FF602E6A7A0 @default.
- Q91018090 P304 Q91018090-028AE8C4-7D99-4157-8A08-E2364F812518 @default.
- Q91018090 P31 Q91018090-E71DB709-1467-44DC-9679-E2DEB11C3BC4 @default.
- Q91018090 P356 Q91018090-44E4AA0D-80BC-42AA-8F45-244F20378A01 @default.
- Q91018090 P433 Q91018090-39A7AD16-F6C6-4482-973C-7A5D4AA8F758 @default.
- Q91018090 P478 Q91018090-F1474147-6225-4266-80D3-84426471DA70 @default.
- Q91018090 P50 Q91018090-0FB1F2F9-DEE0-4043-9010-D5BB9F76DEBA @default.
- Q91018090 P50 Q91018090-257E8510-4D61-4F89-8D4D-222FF3B43BBC @default.
- Q91018090 P577 Q91018090-097CD354-6367-456D-B5D5-58BB364FAC14 @default.
- Q91018090 P698 Q91018090-3CC6A813-FAA7-4561-888E-C56CCACB5BA4 @default.
- Q91018090 P921 Q91018090-C70BD2CA-4A5E-4781-AA28-20F56C0F3E46 @default.
- Q91018090 P356 JAD-180595 @default.
- Q91018090 P698 30636738 @default.
- Q91018090 P1433 Q6294755 @default.
- Q91018090 P1476 "Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease" @default.
- Q91018090 P2093 "Alireza Atri" @default.
- Q91018090 P2093 "Jeffrey L Cummings" @default.
- Q91018090 P2093 "José Luis Molinuevo" @default.
- Q91018090 P2093 "Lutz Frölich" @default.
- Q91018090 P2093 "Marie A Geist" @default.
- Q91018090 P2093 "Neli Boneva" @default.
- Q91018090 P2093 "Pierre N Tariot" @default.
- Q91018090 P304 "303-313" @default.
- Q91018090 P31 Q13442814 @default.
- Q91018090 P356 "10.3233/JAD-180595" @default.
- Q91018090 P433 "1" @default.
- Q91018090 P478 "67" @default.
- Q91018090 P50 Q40279915 @default.
- Q91018090 P50 Q41046481 @default.
- Q91018090 P577 "2019-01-01T00:00:00Z" @default.
- Q91018090 P698 "30636738" @default.
- Q91018090 P921 Q11081 @default.